Riskpilot← Back to searchSign inGet full accessPS Träning & Behandling AB
ABActiveOrg 5592810575Järva Skjutbaneväg 46Physiotherapy activities · NACE 8695Est. 20202 employees
Revenue 2025
SEK 2M
+46% vs 2024
EBITDA margin
20.1%
+1709% vs 2024
Equity ratio
71.1%
Financial strength
Net profit 2025
SEK 307K
+2529% vs 2024
| Revenue | SEK 2M | +46% |
| EBITDA | SEK 396K | +1709% |
| Net profit | SEK 307K | +2529% |
| Total assets | SEK 972K | +90% |
| Equity | SEK 691K | +80% |
| Employees | 2 | — |
Legal name
PS Träning & Behandling AB
Org number
5592810575
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
4 november 2020
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamheten kommer att bedriva personlig träning enskilt och i grupper, massage, naprapatbehandlingar samt föreläsningar inom träning och hälsa.
Address
Järva Skjutbaneväg 46
Email
info@pstraning.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 396 | 1 236 | 1 365 | 1 351 | 1 971 |
| Staff expenses | — | −931 | −1 005 | −991 | −1 000 |
| EBITDA | 459 | −47 | 78 | −25 | 396 |
| Depreciation & amort. | −0 | — | −1 | −10 | −10 |
| EBIT | 459 | −47 | 77 | −35 | 386 |
| Net financials | — | — | 3 | 3 | −0 |
| Profit before tax | 344 | 49 | 80 | −13 | 385 |
| Tax | −74 | −12 | −16 | — | −78 |
| Net profit | 270 | 37 | 64 | −13 | 307 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 647 | 546 | 555 | 512 | 972 |
| Equity | 295 | 332 | 396 | 384 | 691 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 237 | 194 | 140 | 128 | 281 |
| Total debt | 237 | 194 | 140 | 128 | 281 |
EBITDA margin
20.1%
This company
15.8%
Market median
+27% vs market
20212025
Equity ratio
71.1%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
44.5%
This company
18.4%
Market median
+142% vs market
20212025
Net profit margin
15.6%
This company
8.1%
Market median
+93% vs market
20212025
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PL Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PS Träning & Behandling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pia Lena Maria Jutebrink | Chief Executive Officer | 0 companies |
| Fredrik Anders Jutebrink | Deputy Board Member | 0 companies |
| Silje Vik Vilval | Chairman | 0 companies |